Remove Cardiothoracic Remove Outcomes Remove Research
article thumbnail

Patients Who Received Ross Procedure Demonstrate Excellent Survival Rates after 20 Years

Society of Thoracic Surgeons - Adult Cardiac

We wanted to examine our outcomes, and we were pleasantly surprised to find that the freedom from re-intervention was 91% at 10 years and 87% at 20 years. at 5,10,15 and 20 years respectively, the researchers reported. The Societys mission is to improve the lives of patients with cardiothoracic diseases. at 5 years, 94.3%

article thumbnail

Staten Island University Hospital's Cardiothoracic Program Achieves Prestigious STS Three-Star Quality Ratings

DAIC

The cardiothoracic surgery programs at four Northwell Health hospitals received this distinguished accolade, showcasing their commitment to delivering exceptional care and achieving outstanding outcomes. This prestigious recognition places SIUH in the top echelons of surgical excellence.

article thumbnail

Surgeon Preference Impacts Survival Outcomes Analyses for CABG Patients

DAIC

The researchers found that patients who received multi-arterial grafting (MAG) had improved survival over those who received single-arterial grafting (SAG), supporting findings from prior retrospective studies. A study presented at The Society of Thoracic Surgeons 61st Annual Meeting explores findings in more than a million U.S.

article thumbnail

TAVR System Shows Durable Clinical Outcomes, Strong Valve Performance in Low-Risk Aortic Stenosis Patients

DAIC

tim.hodson Mon, 03/31/2025 - 15:39 March 30, 2025 Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Allison Family Distinguished Chair of Cardiovascular Research and professor of cardiothoracic surgery at the Houston Methodist Hospital and principal investigator of the trial.

TAVR 52
article thumbnail

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

milla1cf Mon, 01/29/2024 - 11:00 January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio. They note a substantial increase in the frequency of these surgeries, emphasizing the importance of understanding outcomes.

Research 111
article thumbnail

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

DAIC

The research team followed these patients for a median time of 2.4 years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. years after TAVR and 4.9 The primary focus was on 5-year survival rates. for SAVR vs. 0.4%

article thumbnail

Early and late clinical outcomes and cost-effectiveness of aortic valve replacement using the Inspiris Resilia bioprosthesis

Journal of Cardiothoracic Surgery

Background The present study aimed to critically revise the published literature on clinical outcomes and cost-effectiveness of Inspiris Resilia valve. Full text research articles discussing clinical or cost-effectiveness aspects of Inspiris Resilia bioprosthesis published in English were included in this analysis.